Novedex XT from GASPARI NUTRITION on sale. Find information about GASPARI NUTRITION

Manufacturer's Description:
Gaspari Nutrition, the name you trust, has done it again with Novedex XT™. In a recent clinical trial, this amazing non-anabolic and non-androgenic supplement yielded results greater than those of any other product of its kind in the supplement marketplace. Novedex XT™ has been shown to help significantly increase natural testosterone production and minimize the production of any and all estrogens in the body. With its unprecedented 1-2 punch, this product could be the safest and most effective natural way to trigger a potent and sustained physiological response in order to gain lean mass, strength and endurance while helping to achieve that dry and ripped look. Novedex XT™ - another fine product from Gaspari Nutrition™. The brand that works.

Supplement Facts
Serving Size:1 capsule Servings per Container: 60

Ingredient	Amount	% Daily Value**
Proprietary Blend	30mg	†

** Percent Daily Value is based on a 2000 calorie diet. Your daily values may be higher or lower depending on your calorie needs. † Daily Value not established.

Ingredients:
Other Ingredients: Maltodextrin, Magnesium Stearate, Silica.

Manufacturer's Directions:
As a dietary supplement, take 2 to 4 capsules at night. For best results, use for 4 to 8 weeks. Do not exceed 8 weeks of continuous use. Always check with a knowledgeable physician or health care practitioner before using any dietary supplement.

Manufacturer's Disclaimer:
Consult with a licensed physician before using this product. Do not take this product if you have prostate hypertrophy, liver disease, kidney or heart disease. This product should not be taken by women. In particular, those women who are pregnant, lactating or trying to become pregnant. Do not take this product if you have been diagnosed with high cholesterol, prostate cancer, testicular cancer or breast cancer or are under the age of 18.

GASPARI NUTRITION Novedex XT 60 caps

GASPARI NUTRITION
Novedex XT 60 caps